eXeX, a medical technology company utilizing AI and spatial computing to optimize surgical procedures, announced the closing of a $5.8 million seed round.
Launched in 2022, eXeX built a transformative platform that enables surgical teams to onboard staff and complete surgical procedures with increased efficiency and accuracy. And the company has patented its technology – which has been utilized in over 2,000 live surgeries across three continents, driving favorable results.
Along with the funding milestone, eXeX also announced the appointment of Michael Dykier as Chief Technology Officer (CTO). Dykier joins eXeX from DAS Labs, where he was the founder and a pioneer in mixed reality-based software development. And he brings extensive experience with artificial intelligence and immersive technology to the team.
The funding will be used to accelerate the development of the platform and support its upcoming commercial debut. And eXeX is set to launch commercially in early 2025, with initial availability at select hospitals across the US and UK.
KEY QUOTES:
“We are grateful for our investment partners and alpha sites for their participation and brilliant insights that have contributed to our purposeful evolution forward, hitting every milestone to date.”
- Dr. Robert Masson, CEO of eXeX
“I am excited to join eXeX at such a pivotal time. The company’s innovative approach to integrating AI and spatial computing in surgical procedures is truly groundbreaking. I look forward to contributing to the next phase of development and ensuring our technology transforms surgical practices worldwide.”
- Michael Dykier
